Two weeks vs. four weeks: race to find faster, gentler prostate cancer treatment
NCT ID NCT04422132
Summary
This study is testing if a much shorter, 2-week radiation schedule is as safe and effective as a standard 4-week schedule for men whose prostate cancer returns after surgery. It will compare side effects like bowel and urinary problems, quality of life, and how well the cancer is controlled. The goal is to find a more convenient treatment that doesn't compromise results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.